# Twist Bioscience Corporation (TWST) FY2026 Q3 Balance Sheet

- Company: Twist Bioscience Corporation (TWST)
- Period: As of 2026-06-30
- Filing: Q3 FY2026 10-Q, filed 2026-08-03, accession number 0001581280-26-000047
- Page: https://plicit.ai/financials/twst/fy2026-q3-balance-sheet
- Chart image: https://plicit.ai/charts/twst-fy2026-q3-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 672,437,000 US dollars
- **Current assets**: 321,295,000 US dollars
- **Non-current assets**: 351,142,000 US dollars
- **Liabilities**: 226,698,000 US dollars
- **Current liabilities**: 120,255,000 US dollars
- **Non-current liabilities**: 106,443,000 US dollars
- **Equity**: 445,739,000 US dollars
- **Cash and cash equivalents**: 117,436,000 US dollars
- **Accounts receivable, net**: 65,055,000 US dollars
- **Prepaid expenses and other current assets**: 54,239,000 US dollars
- **Short-term investments**: 49,403,000 US dollars
- **Inventories**: 35,162,000 US dollars
- **Property and equipment, net**: 111,888,000 US dollars
- **Goodwill**: 82,195,000 US dollars
- **Operating lease right-of-use assets**: 68,736,000 US dollars
- **Investment in equity securities**: 68,087,000 US dollars
- **Intangible assets, net**: 12,730,000 US dollars
- **Other non-current assets**: 5,376,000 US dollars
- **Restricted cash, non-current**: 2,130,000 US dollars
- **Accrued expenses and other current liabilities**: 59,703,000 US dollars
- **Accrued compensation**: 34,879,000 US dollars
- **Accounts payable**: 17,043,000 US dollars
- **Current portion of operating lease liability**: 8,630,000 US dollars
- **Operating lease liability, net of current portion**: 84,960,000 US dollars
- **Liability related to the sale of future revenue**: 15,000,000 US dollars
- **Other non-current liabilities**: 6,483,000 US dollars
- **Additional paid-in capital**: 1,875,550,000 US dollars
- **Common stock, $0.00001 par value —200,000 and 200,000 shares authorized at June 30, 2026 and September 30, 2025, respectively; 62,674 and 60,632 shares issued and outstanding at June 30, 2026 and September 30, 2025, respectively**: 1,000 US dollars
- **Accumulated deficit**: negative 1,429,157,000 US dollars
- **Accumulated other comprehensive loss**: negative 655,000 US dollars
- **Gross equity (calculated)**: 1,875,551,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.